| Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants HF Tseng, BK Ackerson, Y Luo, LS Sy, CA Talarico, Y Tian, KJ Bruxvoort, ... Nature medicine 28 (5), 1063-1071, 2022 | 550 | 2022 |
| Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ... bmj 375, 2021 | 233 | 2021 |
| Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ... The Lancet Regional Health - Americas, 2021 | 103 | 2021 |
| Selenium and type 2 diabetes: systematic review LN Kohler, J Foote, CP Kelley, A Florea, C Shelly, HHS Chow, P Hsu, ... Nutrients 10 (12), 1924, 2018 | 103 | 2018 |
| Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5 HF Tseng, BK Ackerson, KJ Bruxvoort, LS Sy, JE Tubert, GS Lee, JH Ku, ... Nature Communications 14 (1), 189, 2023 | 83 | 2023 |
| Higher plasma selenium concentrations are associated with increased odds of prevalent type 2 diabetes LN Kohler, A Florea, CP Kelley, S Chow, P Hsu, K Batai, K Saboda, ... The Journal of Nutrition 148 (8), 1333-1340, 2018 | 64 | 2018 |
| Interim estimates of 2021–22 seasonal influenza vaccine effectiveness—United States, February 2022 JR Chung MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 43 | 2022 |
| mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States HF Tseng, BK Ackerson, LS Sy, JE Tubert, Y Luo, S Qiu, GS Lee, ... Nature Communications 14 (1), 5851, 2023 | 41 | 2023 |
| Influenza vaccine effectiveness against influenza A (H3N2)-related illness in the United States during the 2021–2022 influenza season AM Price, B Flannery, HK Talbot, CG Grijalva, KJ Wernli, CH Phillips, ... Clinical Infectious Diseases 76 (8), 1358-1363, 2023 | 41 | 2023 |
| Recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults KJ Bruxvoort, B Ackerson, LS Sy, A Bhavsar, HF Tseng, A Florea, Y Luo, ... The Journal of Infectious Diseases 225 (11), 1915-1922, 2022 | 36 | 2022 |
| Ethnic disparities in gastric cancer presentation and screening practice in the United States: analysis of 1997–2010 surveillance, epidemiology, and end results-medicare data A Florea, HE Brown, RB Harris, E Oren Cancer Epidemiology, Biomarkers & Prevention 28 (4), 659-665, 2019 | 26 | 2019 |
| Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ... MedRxiv, 2021.09. 29.21264199, 2021 | 25 | 2021 |
| Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5 HF Tseng, BK Ackerson, KJ Bruxvoort, LS Sy, JE Tubert, GS Lee, JH Ku, ... Medrxiv, 2022.09. 30.22280573, 2022 | 22 | 2022 |
| Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System—California, March–July 2021 DE Malden MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 21 | 2021 |
| Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐and Delta‐related outpatient illness among adults, October 2021–February 2022 SS Kim, JR Chung, HK Talbot, CG Grijalva, KJ Wernli, E Kiniry, ET Martin, ... Influenza and Other Respiratory Viruses 16 (6), 975-985, 2022 | 18 | 2022 |
| Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study A Florea, LS Sy, Y Luo, L Qian, KJ Bruxvoort, BK Ackerson, GS Lee, ... PLoS One 17 (4), e0267824, 2022 | 18 | 2022 |
| A multinational assessment of gastric, esophageal, and colorectal cancer burden: a report of disease incidence, prevalence, and fatality A Florea, L Sangaré, K Lowe Journal of Gastrointestinal Cancer 51, 965-971, 2020 | 16 | 2020 |
| Effectiveness of messenger RNA-1273 vaccine booster against coronavirus disease 2019 in immunocompetent adults A Florea, LS Sy, L Qian, BK Ackerson, Y Luo, JE Tubert, GS Lee, JH Ku, ... Clinical Infectious Diseases 76 (2), 252-262, 2023 | 14 | 2023 |
| Effectiveness of mRNA-1273 against Delta KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ... Mu, and other emerging variants. medRxiv 2021 (29.21264199), 2021 | 14 | 2021 |
| Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study JH Ku, LS Sy, L Qian, BK Ackerson, Y Luo, JE Tubert, GS Lee, A Florea, ... Vaccine 41 (24), 3636-3646, 2023 | 13 | 2023 |
Connor KelleyUniversity of ArizonaVerified email at email.arizona.edu